DEA Final Rule for Opioid Use Disorder Drugs

PUBLISHED: Jan 29, 2018
Relevant to: Ambulatory Care, Critical Access Hospitals, Hospitals, Medical Office, Pharmacy

The Drug Enforcement Administration (DEA) has published a final rule implementing the Addiction and Recovery Act (CARA) of 2016, which became law on July 22, 2016 and amended the Controlled Substances Act (CSA) to expand the categories of practitioners who may, under certain conditions on a temporary basis, dispense a narcotic drug in Schedule III, IV, or V for the purpose of maintenance treatment or detoxification treatment.

Prior to CARA, only qualified physicians were permitted to dispense narcotic drugs for the purpose of maintenance treatment or detoxification treatment without being separately registered as a narcotic treatment program. CARA now temporarily permits (until 2021) certain nurse practitioners and physician assistants, who qualif, to dispense these medications if they meet certain criteria, including:

  • The nurse practitioner or physician assistant is licensed under State law to prescribe schedule III, IV, or V medications for the treatment of pain;
  • The nurse practitioner or physician assistant must complete not fewer than 24 hours of initial training.
  • The nurse practitioner or physician assistant is supervised by, or works in collaboration with, a qualifying physician, if the nurse practitioner or physician assistant is required by State law to prescribe medications for the treatment of opioid use disorder in collaboration with or under the supervision of a physician.

Follow the link below to review the final rule.

Want to read the full alert and receive alert emails?

Browse Additional Alerts